Chest. 2021 Apr 13:S0012-3692(21)00689-9. doi: 10.1016/j.chest.2021.04.004. Online ahead of print.
The COVID-19 pandemic has had devastating medical and economic consequences globally. The severity of COVID-19 is related, in a large measure, to the extent of pulmonary involvement. The role of chest CT in the management of patients with COVID-19 has evolved since the onset of the pandemic. Specifically, the description of CT findings, use of CT chest in various acute and subacute settings and its usefulness in predicting chronic disease have been better defined. We performed a review of published data on CT scans in COVID-19 patients. A summary of the range of imaging findings, from typical to less common abnormalities is provided. Familiarity with these findings may facilitate in the diagnosis and management of this disease. A comparison of sensitivity and specificity of CT chest with RT-PCR testing highlights the potential role of CT imaging in difficult to diagnose cases of Covid-19. The utility of CT imaging to assess prognosis, guide management, and identify acute pulmonary complications associated with SARS-COV-2 is highlighted. Beyond the acute stage, it is important for clinicians to recognize pulmonary parenchymal abnormalities, progressive fibrotic lung disease and vascular changes that may be responsible for persistent respiratory symptoms. A large collection of multi institutional images has been included to elucidate the CT findings described.
PMID:33861993 | DOI:10.1016/j.chest.2021.04.004